Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
09/2003
09/25/2003US20030181335 As an example, 3-(4-Cyano-3-methoxyphenyl)-6-trifluoromethyl-1,2,3,4-tetrahydropyrimidine -2,4-dione; very active herbicides and/or for the desiccation and/or defoliation of plants; better control of weeds
09/25/2003US20030181334 Herbicidal method
09/25/2003CA2478048A1 Novel florfenicol-type antibiotics
09/24/2003EP1346985A1 Pyrimidine derivatives and process for preparing the same
09/24/2003EP1345920A1 Novel sulfamides and their use as endothelin receptor antagonists
09/24/2003EP1345910A1 Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
09/24/2003EP1345905A1 Potassium channel inhibitors
09/24/2003EP1345902A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
09/24/2003EP1345889A1 Method for the regioselective preparation of substituted benzo g]quinoline-3-carbonitriles and benzo g]quinazolines
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/24/2003EP1200093B1 Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of gi disorders
09/24/2003EP1196419B1 Potassium channel blocking agents
09/24/2003EP1042302B1 Liquid crystal compounds having a chiral fluorinated terminal portion
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444563A Quinoline and quinazoline derivatives
09/24/2003CN1122040C Suger modified nucleosides and their use of synthesis of oligonucleotide
09/24/2003CN1122037C Thiophene [2,3,-d] hybar X compound and its preparing method, use and medical composition containing it
09/23/2003US6624309 Administering 4-heterocyclicbenzamide derivative
09/23/2003US6624120 Substituted herbicidal phenyluracils
09/23/2003US6624119 3-[Benz(ox/thi)azol-7-yl]-1h-pyrimidine-2,4-diones
09/23/2003US6624117 Organic electron acceptor (developer) and colorless or pale colored electron donative compound (color forming compound)
09/23/2003CA2127110C Carbamates and crop protection agents containing them
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076427A1 Quinazoline compounds useful in therapy
09/18/2003WO2003076422A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076418A1 Quinazolinone modulators of nuclear receptors
09/18/2003WO2003076417A2 Oxo-azabicyclic compounds
09/18/2003WO2003076416A1 Oxo azabicyclic compounds
09/18/2003WO2003076415A1 Pyrimidine compounds and their use as pesticides
09/18/2003WO2003076414A2 Aryl substituted pyrimidines and the use thereof
09/18/2003WO2003076406A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003WO2003076401A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076395A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075836A2 Cathepsin cysteine protease inhibitors
09/18/2003WO2003053368A3 Chalcone derivatives and their use to treat diseases
09/18/2003WO2002062750A9 Cannabinoid receptor ligands
09/18/2003US20030176700 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin-7-ones
09/18/2003US20030176697 Such as 2-(methylsulfanyl)-6-(3,5-dimethyoxyphenyl)-8-ethyl-8H-pyrido(2,3-d) -pyrimidine-7-one; antitumor agents; calcium channel blockers
09/18/2003US20030176696 Preparing pyrazolopyrimidinone derivatives for the treatment of impotence
09/18/2003US20030176451 Reacting a heterocyclic-methanesulfonyl substituted-quinazolineamine compound with amine compound
09/18/2003US20030176415 1,2,3,4-tetrahydroisoquinoline derivatives
09/18/2003US20030176392 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus or Kaposi's sarcoma-associated herpes ("KHSV")
09/18/2003CA2479036A1 Aryl substituted pyrimidines and the use thereof
09/18/2003CA2479016A1 Quinazoline compounds useful in therapy
09/18/2003CA2478706A1 Oxo-azabicyclic compounds
09/18/2003CA2478652A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/17/2003EP1344775A1 Preparation of fungicidal quinazolinones and useful intermediates
09/17/2003EP1344525A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
09/17/2003EP1343907A1 Method for the continuous biotechnological production of compatible solutes from toxic substrates
09/17/2003EP1343782A1 Pyrimidineamines as angiogenesis modulators
09/17/2003EP1343781A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
09/17/2003EP1343505A1 Cxcr3 antagonists
09/17/2003EP1343477A2 Treatment of inoperable tumors by stereotactic injection of microspheres
09/17/2003EP1196411B1 Bradykinin b1 receptor antagonists
09/17/2003EP1119529B1 Chemical constructs
09/17/2003EP0977737B1 Crf antagonistic quino- and quinazolines
09/17/2003EP0754682B9 Aminostilbazole derivative and medicine
09/17/2003CN1443179A Aniline derivatives
09/17/2003CN1443175A Process for preparation of 4,6-dimethoxy-2-(methylsulfonyl)-1,3-pyrimidine
09/17/2003CN1443174A Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
09/17/2003CN1443159A Substituted sulfonyl aminomethyl benzoic acid (derivatives) and method for production thereof
09/17/2003CN1442403A Chiral alkamine ligand and its application in asymmetrical addition of terminal alkyne para imine
09/17/2003CN1121394C Substituted phenyluracils
09/17/2003CN1121393C Substituted aminosalicyclic acid amides with fungicidal effect and intermediate products for production thereof
09/17/2003CN1121392C Substituted pyrimidine (thi) ones
09/17/2003CN1121138C Fungicide salts
09/16/2003US6620933 Dyes having acid reistance and stability used as colors for silver halide photographic, photosensitive materials, ink jet or thermal printing and as toners in electrophotography, electroluminescence or television displays
09/16/2003US6620932 2-alkoxy-5-methoxypyrimidines or their tautomeric forms and methods for producing the same
09/16/2003US6620817 Antiinflammatory, antiarthritic agents; autoimmune and rheumatic diseases
09/16/2003CA2068089C Method and compositions for using non-ionic contrast agents to reduce the risk of clot formulation in diagnostic procedures
09/12/2003WO2003074496A1 Halobenzyl substituted phenylaceto esters and amides and use thereof for prevention of harmful organisms
09/12/2003WO2003074495A1 Hppars activators
09/12/2003WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/11/2003US20030171411 Amide derivatives as therapeutic agents
09/11/2003US20030171387 Anticancer agents
09/11/2003US20030171386 Small molecules for the treatment of abnormal cell growth
09/11/2003US20030171384 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
09/11/2003US20030171374 Viricides; prevent reproduction of human T-Cell lymphocyte virus
09/11/2003US20030171361 Treatment of impotence, sexual dysfunction in female, stable, unstable and variant angina, hypertension, pulmonary hypertension, congestive heart failure, atherosclerosis
09/11/2003US20030171359 Suitable for treatment of illnesses characterised by excessive or abnormal cell proliferation; viral, bacterial, fungal and/or parasitic infections, skin diseases, bone diseases, cardiovascular diseases
09/11/2003US20030170381 Piezoelectric element and process for production thereof
09/10/2003EP1342718A1 Method and reagents for n-alkylating ureides
09/10/2003EP1341793A2 Crf receptor antagonists and methods relating thereto
09/10/2003EP1341785A2 HYDROLYSIS OF R(R*,R*)]-2-(4-FLUOROPHENYL)-$g(b),$g(d) -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- (PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE
09/10/2003EP1341780A2 Substituted heterocyclic phthalic acid diamide arthropodicides
09/10/2003EP1341773A2 Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
09/10/2003EP1341772A2 Quinazolinones and pyridinylpyrimidinones for controlling invertebrate pests
09/10/2003EP1341764A1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
09/10/2003EP1037592B1 New developer combinations for oxidation colouring agents
09/10/2003CN1441802A Process for preparing pyrazolopyrimidinone derivatives for treatment of impotence
09/10/2003CN1441788A Novel arylethene-sulfonamides compounds
09/10/2003CN1440971A Vitronectin receptor antagnist, its preparation and use
09/10/2003CN1440962A Substituted amino amide salicylate with Fungal killing function and tis prepared intermediate thereof
09/10/2003CN1120878C Method for coal liquefaction
09/10/2003CN1120836C 2-pirimioxybenzyl substituted pyridyl amine derivative
1 ... 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 ... 427